US · USD
NBIX
Neurocrine Biosciences Inc
- Day's range
- $142.48 – $146.92
- Day's volume
- $240.9M
- 52-week range
- $123.10 – $185.50
Follow NBIX in the Fuolio
See how NBIX weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountNBIX in numbers
- Market cap
- $14.7B
- P/E
- 20.78
- P/B
- 3.97
- Dividend yield (12m)
- 0.00%
NBIX trades at 20.78 times its earnings of the last 12 months.
NBIX price history
NBIX risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -5.22% | +23.69% | +73.23% |
| Volatility (annualized) | 26.52% | 27.47% | 25.61% |
| Largest drawdown | -15.84% | -29.07% | -29.54% |
| Positive months | 4/12 | 20/36 | 34/60 |
How much did investing in NBIX return?
$1,000.00 invested on 11/01/2021 would be worth $1,732.25 today.
- Value today in NBIX
- $1,732.25
- Return over the period
- +73.23%
- Return per year
- +11.80%
- In the S&P 500
- $1,702.20
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
NBIX fundamentals
Valuation
- P/E20.78
- P/B3.97
- EV/EBITDA—
- EV/EBIT18.44
- EV/Revenue4.34
- P/EBIT18.44
- P/S4.34
- P/OCF16.32
- P/FCF16.84
- Earnings yield5.42%
- PEG ratio—
- Earnings per share$6.94
- Book value per share$36.34
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio1.87
- Quick ratio1.75
- Cash ratio0.38
Efficiency
- Gross margin—
- EBITDA margin—
- Operating margin23.56%
- Net margin20.91%
- Asset turnover0.63
Profitability
- ROE19.10%
- ROA13.16%
- ROIC16.15%
- Payout0.00%
Growth
- Revenue CAGR (5 years)26.74%
- Earnings CAGR (5 years)14.11%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is NBIX's fair price?
Two classic value formulas, with today's numbers. The current price is $144.21.
- Graham's fair price
- $75.33
- 47.76% below the price
√(22.50 × $6.94 × $36.34)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to NBIX: it paid no distributions in the last five years.
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
NBIX's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 29.74 | 39.88 | 52.51 | 74.67 | 90.53 | 22.11 | 268.12 | 307.37 |
| P/B | 4.38 | 5.26 | 5.87 | 6.76 | 5.90 | 8.00 | 15.58 | 13.49 |
| EV/EBITDA | — | — | — | — | — | — | — | 158.87 |
| Earnings per share | $4.77 | $3.42 | $2.51 | $1.60 | $0.94 | $4.34 | $0.40 | $0.23 |
| Book value per share | $32.41 | $25.97 | $22.43 | $17.68 | $14.43 | $11.99 | $6.90 | $5.29 |
| ROE | 14.71% | 13.18% | 11.19% | 9.05% | 6.52% | 36.17% | 5.81% | 4.39% |
| ROIC | 12.91% | 15.47% | 8.45% | 10.53% | 6.59% | 14.47% | 9.03% | 7.41% |
| Gross margin | 98.18% | 98.56% | 97.90% | 98.44% | 98.74% | 99.03% | — | 98.92% |
| EBITDA margin | — | — | — | — | — | — | — | 9.05% |
| Net margin | 16.73% | 14.49% | 13.23% | 10.38% | 7.90% | 38.94% | 4.69% | 4.68% |
NBIX's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $2.9B | $2.4B | $1.9B | $1.5B | $1.1B | $1B |
| Cost of revenue | -$52.1M | -$34M | -$39.7M | -$23.2M | -$14.3M | -$10.1M |
| Gross profit | $2.8B | $2.3B | $1.8B | $1.5B | $1.1B | $1B |
| EBITDA | — | — | — | — | — | — |
| EBIT | $619.1M | $570.5M | $250.9M | $249M | $102.5M | $163M |
| Financial result | $86.3M | -$84.5M | $81.2M | -$35.1M | -$1.1M | -$56.3M |
| Income before tax | $705.4M | $486M | $332.1M | $213.9M | $101.4M | $106.7M |
| Income tax | -$226.8M | -$144.7M | -$82.4M | -$59.4M | -$11.8M | $300.6M |
| Net income | $478.6M | $341.3M | $249.7M | $154.5M | $89.6M | $407.3M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does NBIX pay dividends?
NBIX has no distributions on record.
About Neurocrine Biosciences
- Sector
- Manufacturing
Questions about NBIX
How much is NBIX today?
NBIX is at $144.21 (0.72% on the day), last traded on 10/05/2026.
What are the P/E and P/B of NBIX?
NBIX trades at a P/E of 20.78 and a P/B of 3.97.
How much did NBIX return in 12 months?
NBIX returned -5.22% in 12 months, with annualized volatility of 26.52% and a largest drawdown of -15.84%.